Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24204
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVerstockt, B.-
dc.contributor.authorARIJS, Ingrid-
dc.contributor.authorde Bruyn, M.-
dc.contributor.authorVerstockt, S.-
dc.contributor.authorVan Assche, G.-
dc.contributor.authorBreynaert, C.-
dc.contributor.authorVermeire, S.-
dc.contributor.authorFerrante, M.-
dc.date.accessioned2017-08-11T08:44:36Z-
dc.date.available2017-08-11T08:44:36Z-
dc.date.issued2017-
dc.identifier.citationJOURNAL OF CROHNS & COLITIS, 11, p. S96-S97 (Art N° P035)-
dc.identifier.issn1873-9946-
dc.identifier.urihttp://hdl.handle.net/1942/24204-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.titleTNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab-
dc.typeJournal Contribution-
dc.identifier.epageS97-
dc.identifier.spageS96-
dc.identifier.volume11-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Verstockt, B.; Arijs, I.; de Bruyn, M.; Van Assche, G.; Vermeire, S.; Ferrante, M.] Katholieke Univ Leuven, Dept Clin & Expt Med, TARGID IBD, Leuven, Belgium. [Verstockt, B.] Univ Cambridge, Sch Clin Med, Dept Med, Biomed Campus, Cambridge, England. [Verstockt, B.] Cambridge Inst Med Res, Cambridge, England. [Arijs, I.] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium. [Arijs, I.] Jessa Hosp, Hasselt, Belgium. [de Bruyn, M.] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium. [Verstockt, S.] Katholieke Univ Leuven, Lab Complex Genet, Dept Human Genet, Leuven, Belgium. [Van Assche, G.; Vermeire, S.; Ferrante, M.] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium. [Breynaert, C.] Katholieke Univ Leuven, Clin Immunol Lab, Dept Microbiol & Immunol, Leuven, Belgium.-
local.publisher.placeOXFORD-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrP035-
local.classdsPublValOverrule/author_version_not_expected-
dc.identifier.isi000398606900163-
dc.identifier.urlhttps://www.ecco-ibd.eu/index.php/publications/congress-abstract-s/abstracts-2017/item/p035-tnf-driven-pathways-are-increased-at-baseline-in-crohn-s-disease-patients-not-responding-to-infliximab.html-
item.fulltextWith Fulltext-
item.fullcitationVerstockt, B.; ARIJS, Ingrid; de Bruyn, M.; Verstockt, S.; Van Assche, G.; Breynaert, C.; Vermeire, S. & Ferrante, M. (2017) TNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab. In: JOURNAL OF CROHNS & COLITIS, 11, p. S96-S97 (Art N° P035).-
item.contributorVerstockt, B.-
item.contributorARIJS, Ingrid-
item.contributorde Bruyn, M.-
item.contributorVerstockt, S.-
item.contributorVan Assche, G.-
item.contributorBreynaert, C.-
item.contributorVermeire, S.-
item.contributorFerrante, M.-
item.accessRightsOpen Access-
crisitem.journal.issn1873-9946-
crisitem.journal.eissn1876-4479-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
P035 TNF.pdfPublished version288.95 kBAdobe PDFView/Open
Show simple item record

Page view(s)

16
checked on Sep 7, 2022

Download(s)

6
checked on Sep 7, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.